Promoters Sanjay Jain and Fateh Pal Singh have disposed of a combined 12.91% equity stake in Onyx Biotec Limited through open market transactions on the National Stock Exchange (NSE). The sales, executed on June 19, 2026, were disclosed to the company in compliance with Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The total value of the transactions amounted to ₹8.11 crore, excluding taxes and brokerage charges.

Sanjay Jain sold 10,00,000 equity shares, representing 5.52% of the company's shareholding, for a total consideration of ₹3.41 crore. Prior to the disposal, Jain held 21,20,600 shares (11.70%). Post-transaction, his holding has reduced to 11,20,600 shares, which accounts for 6.18% of the paid-up share capital. The trade was executed on the NSE through the market mechanism.

Fateh Pal Singh divested 13,40,000 equity shares, amounting to 7.39% of the company, for ₹4.70 crore. Before this sale, Singh held 34,37,600 shares (18.96%). Following the disposal, his stake stands at 20,97,600 shares, equating to 11.57% of the equity. Like Jain, Singh executed the trade on the NSE on June 19, 2026, and formally intimated the company on June 23, 2026.

Breakdown of Share Disposal

The following table details the changes in shareholding for both promoters:

Onyx Biotec Limited submitted the disclosures to the NSE on June 24, 2026, under Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The confirmations were signed by Harsh Mahajan, CEO/CFO/WTB of the company. Neither promoter reported any trading in derivatives during the relevant period.

Onyx Biotec Ltd has confirmed that no encumbrance was created on its shares during the financial year ended March 31, 2026. The disclosure, submitted to the National Stock Exchange of India Limited, ensures compliance with SEBI regulations regarding substantial acquisition of shares and takeovers.

Managing Director Sanjay Jain provided the declaration on behalf of the promoters, promoter group, and persons acting in concert. The filing confirms that no shares were encumbered directly or indirectly throughout FY26.

The submission was made under Regulation 31(4) and 31(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. These regulations require periodic disclosures by promoters to maintain transparency regarding shareholding patterns and any potential charges on shares.

The letter, addressed to the Listing Department of the exchange, was digitally signed by Sanjay Jain on April 07, 2026. The company requested that the information be placed on record and acknowledged.